Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BRRZYOTCMKTS:LNGLYOTCMKTS:MXDHFOTCMKTS:RNUGFOTCMKTS:WLFDY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRRZYTotal Brain$5.00$5.00$5.00▼$5.00$53.13M5.180 shsN/ALNGLYLiquefied Natural Gas$0.09-10.0%$0.09$0.03▼$0.45$12.98M0.3648,717 shs26,000 shsMXDHFMDxHealth$0.00$0.25▼$0.35$3.90M1.461,000 shs300 shsRNUGFReNeuron Group$0.00$0.00▼$0.05N/A-0.6325 shsN/AWLFDYWolford Aktiengesellschaft$1.45$1.45$0.99▼$1.49$48.71M0.39100 shs1 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRRZYTotal Brain0.00%0.00%0.00%0.00%0.00%LNGLYLiquefied Natural Gas0.00%0.00%0.00%0.00%0.00%MXDHFMDxHealth0.00%0.00%0.00%0.00%0.00%RNUGFReNeuron Group0.00%0.00%0.00%0.00%0.00%WLFDYWolford Aktiengesellschaft0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRRZYTotal BrainN/AN/AN/AN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/AN/AN/AMXDHFMDxHealthN/AN/AN/AN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/AN/AN/AN/AWLFDYWolford AktiengesellschaftN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRRZYTotal Brain 0.00N/AN/AN/ALNGLYLiquefied Natural Gas 0.00N/AN/AN/AMXDHFMDxHealth 0.00N/AN/AN/ARNUGFReNeuron Group 0.00N/AN/AN/AWLFDYWolford Aktiengesellschaft 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRRZYTotal Brain$2.60M20.43N/AN/A$1.67 per share2.99LNGLYLiquefied Natural GasN/AN/AN/AN/AN/AN/AMXDHFMDxHealth$37.05M0.00N/AN/A$0.60 per share0.00RNUGFReNeuron Group$640KN/AN/AN/AN/AN/AWLFDYWolford Aktiengesellschaft$128.89M0.38$0.07 per share19.71N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRRZYTotal Brain-$5.14MN/A0.00∞N/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/A0.00∞N/AN/AN/AN/AN/AMXDHFMDxHealth-$44.04MN/A0.00N/AN/AN/AN/AN/AN/ARNUGFReNeuron Group-$6.52MN/A0.00N/AN/AN/AN/AN/AN/AWLFDYWolford Aktiengesellschaft-$14.59MN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRRZYTotal BrainN/AN/AN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AN/AN/AMXDHFMDxHealthN/AN/AN/AN/AN/ARNUGFReNeuron GroupN/AN/AN/AN/AN/AWLFDYWolford AktiengesellschaftN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRRZYTotal BrainN/AN/AN/ALNGLYLiquefied Natural GasN/AN/AN/AMXDHFMDxHealth1.451.251.19RNUGFReNeuron GroupN/AN/AN/AWLFDYWolford AktiengesellschaftN/A1.080.41Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRRZYTotal BrainN/ALNGLYLiquefied Natural GasN/AMXDHFMDxHealthN/ARNUGFReNeuron GroupN/AWLFDYWolford AktiengesellschaftN/AInsider OwnershipCompanyInsider OwnershipBRRZYTotal BrainN/ALNGLYLiquefied Natural GasN/AMXDHFMDxHealth1.70%RNUGFReNeuron GroupN/AWLFDYWolford AktiengesellschaftN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRRZYTotal BrainN/A10.63 millionN/ANot OptionableLNGLYLiquefied Natural GasN/A144.17 millionN/ANot OptionableMXDHFMDxHealth25215.60 million15.33 millionNot OptionableRNUGFReNeuron Group26N/AN/ANot OptionableWLFDYWolford Aktiengesellschaft1,08133.60 millionN/ANot OptionableWLFDY, MXDHF, LNGLY, BRRZY, and RNUGF HeadlinesRecent News About These CompaniesWolford appoints Marco Pozzo as deputy CEOJuly 4 at 8:44 AM | fashionunited.inFWolford AG: Stimmrechtsänderung und wichtige Hauptversammlung 2025!July 3 at 5:42 AM | wallstreet-online.deWWolford-Aktie: Beteiligung von Großaktionär Bartel schrumpft nach KapitalerhöhungJuly 1 at 2:18 PM | finanzen.atFEQS-HV: Wolford AG: Einberufung zur 38. ordentlichen Hauptversammlung gem. § 107 Abs 3 AktGJuly 1 at 9:17 AM | ots.atOWolford ADR Aktie | WLFDY Kurs | Realtime - Investing.comJuly 1 at 4:17 AM | de.investing.comWolford-Aktie: Wolford hat Grundkapitalerhöhung umgesetztJune 30, 2025 | finanzen.atFWiener Börse Nebenwerte-Blick: Wolford steigt 10,23 ProzentJune 26, 2025 | boerse-social.comBWolford gibt Ergebnis der Kapitalerhöhung bekanntJune 10, 2025 | fashionunited.deFWiener Börse Nebenwerte-Blick: Wolford steigt mehr als 21 ProzentMay 29, 2025 | boerse-social.comBWolford plant drastische Kapitalerhöhung: Grundkapital soll beinahe verdoppelt werdenMay 20, 2025 | msn.comWolford plant massive KapitalaufstockungMay 19, 2025 | msn.comWolford-Aktie sackt ab: Wolford will Kapital massiv aufstockenMay 19, 2025 | finanzen.atFWolford startet KapitalerhöhungMay 19, 2025 | fashionunited.deFWolford macht über 51 Mio. Euro VerlustMay 13, 2025 | textilwirtschaft.deTWolford wieder tiefer in der VerlustzoneMay 13, 2025 | fashionunited.deFWolford deepens losses againMay 13, 2025 | fashionunited.inFWolford AG veröffentlicht Jahresfinanzbericht: Einblick in die Zukunft!May 11, 2025 | wallstreet-online.deWWolford-Aktie: Wolford erleidet Umsatzeinbruch - Verlust ausgeweitetMay 10, 2025 | msn.comWolford schreibt 52 Millionen Euro VerlustMay 9, 2025 | vorarlberg.orf.atVWolford postpones publication of annual financial statementsMay 1, 2025 | fashionunited.inFMedia Sentiment Over TimeWLFDY, MXDHF, LNGLY, BRRZY, and RNUGF Company DescriptionsTotal Brain OTCMKTS:BRRZY$5.00 0.00 (0.00%) As of 07/23/2021Total Brain Limited, together with its subsidiaries, develops and sells brain health products in the United States. It offers Total Brain, a neuroscience-based mental health and brain performance app. Total Brain Limited has a partnership with the Center for Adolescent Research and Education to address growing youth mental health crisis. The company was formerly known as Brain Resource Limited and changed its name to Total Brain Limited in December 2018. Total Brain Limited was founded in 2000 and is based in Surry Hills, Australia.Liquefied Natural Gas OTCMKTS:LNGLY$0.09 -0.01 (-10.00%) As of 07/2/2021Liquefied Natural Gas Limited, together with its subsidiaries, engages in the identification and progression of liquefied natural gas (LNG) development projects to facilitate the production and sale of LNG. It operates through LNG Infrastructure, and Technology and Licensing segments. The company's projects include the Magnolia LNG project located in Lake Charles, Louisiana, the United States; and the Bear Head LNG project situated in Point Tupper, Richmond County, Nova Scotia, Canada. It also designs, develops, owns, and patents OSMR LNG liquefaction process. The company is headquartered in Houston, Texas.MDxHealth OTCMKTS:MXDHFMDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.ReNeuron Group OTCMKTS:RNUGFReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also develops CTX-derived exosomes that are in the pre-clinical stage, which are Nano-sized vesicles secreted by stem cells. In addition, the company licenses ReNcell products. It has a collaboration agreement with University College London to conduct research into the generation of immune cells from induced pluripotent stem cells for anti-cancer cell therapies. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.Wolford Aktiengesellschaft OTCMKTS:WLFDY$1.45 0.00 (0.00%) As of 01/9/2023Wolford Aktiengesellschaft produces and markets skinwear in Austria, Germany, rest of Europe, North America, and Asia. The company's products include legwear; ready-to-wear; beachwear; swimwear; close-fitting products, such as bodies and shirts; and figure-shaping lingerie, as well as dresses and pullovers. It also offers accessories comprising scarves and belts. The company sells its products through 229 monobrand points of sales approximately 2,500 retail partners. In addition, it operates a restaurant under World of Wolford name located in Bregenz, Austria. The company was founded in 1950 and is headquartered in Bregenz, Austria. Wolford Aktiengesellschaft is a subsidiary of FFG Wisdom (Luxembourg) S.à r.l. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Whiplash for Investors: AeroVironment's Confusing Stock Signals Rocket Lab: Latest Catalysts Bolster the Bull Case Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
